Latest Psychosis Stories
De novo mutations â€“ genetic errors that are present in patients but not in their parents â€“ are more frequent in schizophrenic patients than in normal individuals.
A new study has found that there is no physical explanation for delusional infestations, and those patients who complained of being infected with bugs or eggs generally had a clean report on medical exams.
Schizophrenia is a serious mental disorder that currently affects about one in every 200 people.
Research has identified a critical brain pathway responsible for the effects of cannabinoid drugs on how the brain processes emotional information.
BEERSE, Belgium, April 4, 2011 /PRNewswire/ -- Janssen EMEA -- New data from an independent prospective study presented last week at the 19th European Congress of Psychiatry (EPA 2011) shows treatment with RisperdalÂ® ConstaÂ® (risperidone long-acting injection (RLAI)) is associated with a lower risk of hospitalisation in patients with schizophrenia compared to treatment with other antipsychotics over a 12-month period.
New website and brochure on schizophrenia launched by the National Alliance on Mental Illness Arlington, VA (PRWEB) March 31, 2011 The National Alliance on Mental Illness (NAMI) has launched a new website on schizophrenia and published a new brochure on the medical condition which affects more than 2.4 million American adults each year.
HERZLIYA, Israel, March 25, 2011 /PRNewswire-FirstCall/ -- - MinoGuard, a Private Biotechnology Company Developing Drugs for Mental Health Diseases, With its Lead Compound, SAM-101 for the Treatment of Schizophrenia; - MinoGuard Successfully Completed a 70 Patient Phase 2a Clinical Trial in Schizophrenia - use of the Drug Indicated Improvement of the Positive Symptoms of the Disease as well as Decrease of its Negative Symptoms XTL announced on March 24, 2011, it entered into a...
Physical ill-health is rife among the severely mentally ill in Britain.
Teenagers and young adults who use cannabis are more likely to suffer psychotic symptoms, according to a new study published Tuesday on the British Medical Journal (BMJ) website.
In a major advance for schizophrenia research, an international team of scientists led by the University of California, San Diego School of Medicine and involving Trinity College Dublin researchers has identified a gene mutation strongly linked to schizophrenia that may be an important new target for the development of drug therapies.